Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15927 | 615 | 42.2 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
668 | 12550 | NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | XLP | Author keyword | 54 | 74% | 7% | 40 |
2 | 2B4 | Author keyword | 33 | 66% | 5% | 31 |
3 | X LINKED LYMPHOPROLIFERATIVE DISEASE | Author keyword | 29 | 61% | 5% | 31 |
4 | SH2D1A | Author keyword | 23 | 69% | 3% | 20 |
5 | SLAM ASSOCIATED PROTEIN | Author keyword | 19 | 80% | 2% | 12 |
6 | X LINKED LYMPHOPROLIFERATIVE SYNDROME | Author keyword | 14 | 64% | 2% | 14 |
7 | SLAM FAMILY | Author keyword | 8 | 75% | 1% | 6 |
8 | SAP | Author keyword | 7 | 15% | 7% | 43 |
9 | EAT 2 | Author keyword | 7 | 67% | 1% | 6 |
10 | SLAM FAMILY RECEPTORS | Author keyword | 6 | 80% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | XLP | 54 | 74% | 7% | 40 | Search XLP | Search XLP |
2 | 2B4 | 33 | 66% | 5% | 31 | Search 2B4 | Search 2B4 |
3 | X LINKED LYMPHOPROLIFERATIVE DISEASE | 29 | 61% | 5% | 31 | Search X+LINKED+LYMPHOPROLIFERATIVE+DISEASE | Search X+LINKED+LYMPHOPROLIFERATIVE+DISEASE |
4 | SH2D1A | 23 | 69% | 3% | 20 | Search SH2D1A | Search SH2D1A |
5 | SLAM ASSOCIATED PROTEIN | 19 | 80% | 2% | 12 | Search SLAM+ASSOCIATED+PROTEIN | Search SLAM+ASSOCIATED+PROTEIN |
6 | X LINKED LYMPHOPROLIFERATIVE SYNDROME | 14 | 64% | 2% | 14 | Search X+LINKED+LYMPHOPROLIFERATIVE+SYNDROME | Search X+LINKED+LYMPHOPROLIFERATIVE+SYNDROME |
7 | SLAM FAMILY | 8 | 75% | 1% | 6 | Search SLAM+FAMILY | Search SLAM+FAMILY |
8 | SAP | 7 | 15% | 7% | 43 | Search SAP | Search SAP |
9 | EAT 2 | 7 | 67% | 1% | 6 | Search EAT+2 | Search EAT+2 |
10 | SLAM FAMILY RECEPTORS | 6 | 80% | 1% | 4 | Search SLAM+FAMILY+RECEPTORS | Search SLAM+FAMILY+RECEPTORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LINKED LYMPHOPROLIFERATIVE DISEASE | 120 | 44% | 34% | 209 |
2 | GENE PRODUCT SAP | 105 | 86% | 9% | 54 |
3 | XLP | 56 | 89% | 4% | 25 |
4 | RECEPTOR 2B4 | 52 | 100% | 3% | 18 |
5 | PROTEIN SAP | 42 | 94% | 2% | 15 |
6 | 2B4 CD48 INTERACTIONS | 34 | 93% | 2% | 13 |
7 | CONTROLS T CELL | 33 | 75% | 4% | 24 |
8 | LYMPHOCYTIC ACTIVATION MOLECULE | 27 | 45% | 7% | 45 |
9 | XQ25 | 24 | 91% | 2% | 10 |
10 | 2B4 CD244 | 22 | 54% | 5% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SLAM Family Receptors and SAP Adaptors in Immunity | 2011 | 103 | 283 | 66% |
Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules | 2007 | 122 | 184 | 71% |
Immune regulation by SLAM family receptors and SAP-related adaptors | 2006 | 117 | 103 | 83% |
SLAM receptors and SAP influence lymphocyte interactions, development and function | 2009 | 94 | 66 | 53% |
The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease | 2003 | 178 | 105 | 81% |
Molecular and cellular pathogenesis of X-linked lymphoproliferative disease | 2005 | 128 | 161 | 70% |
Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes | 2007 | 60 | 93 | 63% |
X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma | 2011 | 29 | 168 | 69% |
XLP: Clinical Features and Molecular Etiology due to Mutations in SH2D1A Encoding SAP | 2014 | 3 | 76 | 75% |
The SLAM and SAP gene families control innate and adaptive immune responses | 2008 | 41 | 295 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR BIOL PATHOLIMMUNOL UNIT | 4 | 50% | 1.0% | 6 |
2 | ALERGIA INMUNOL | 3 | 45% | 0.8% | 5 |
3 | BIOTECHNOL BIOSERV UNIT 3149 | 2 | 67% | 0.3% | 2 |
4 | BMT HEMATOL ONCOL | 2 | 67% | 0.3% | 2 |
5 | DAVID R BLOOM PHARMACOL | 1 | 50% | 0.3% | 2 |
6 | HEMATOL ONCOL FELLOWSHIP TRAINING PROGRAM | 1 | 50% | 0.3% | 2 |
7 | INT CONVERGING TECHNOL | 1 | 50% | 0.3% | 2 |
8 | LEPROSY SECT | 1 | 100% | 0.3% | 2 |
9 | SIGNAL TRANSDUCT PATHWAYS | 1 | 100% | 0.3% | 2 |
10 | INFECT DIS FELLOWSHIP TRAINING PROGRAM | 1 | 33% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000172115 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
2 | 0.0000119398 | HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS//HEMOPHAGOCYTIC SYNDROME//HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 | 0.0000108513 | T11TS//CD2//CD58 |
4 | 0.0000102515 | INTERLEUKIN 21//IL 21//FOLLICULAR HELPER T CELLS |
5 | 0.0000097100 | AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL//EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1//JOINT ONCOL PROGRAM |
6 | 0.0000090533 | INFECTIOUS MONONUCLEOSIS//MONONUCLEOSIS//ACUTE EBV INFECTION |
7 | 0.0000068456 | NKG2D//NKG2D LIGANDS//MICB |
8 | 0.0000065709 | KIR//LY49//KILLER CELL IMMUNOGLOBULIN LIKE RECEPTORS |
9 | 0.0000065608 | LAIR 1//CD300A//FCRL |
10 | 0.0000062836 | ECCELLENZA RIC BIOMED//NKG2C//NK CELL MATURATION |